These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22339303)

  • 1. Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.
    Basalious EB; El-Sebaie W; El-Gazayerly O
    Pharm Dev Technol; 2013; 18(2):407-16. PubMed ID: 22339303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.
    Basalious EB; El-Sebaie W; El-Gazayerly O
    AAPS PharmSciTech; 2011 Sep; 12(3):799-810. PubMed ID: 21701960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design.
    Verma S; Singh SK; Verma PR; Ahsan MN
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1358-70. PubMed ID: 23879216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization.
    Palem CR; Kumar Battu S; Gannu R; Yamsani VV; Repka MA; Yamsani MR
    Pharm Dev Technol; 2012; 17(3):321-32. PubMed ID: 21265709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Deliv; 2016 Oct; 23(8):2998-3007. PubMed ID: 26828616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation.
    Abdelbary G; Amin M; Salah S
    Pharm Dev Technol; 2013; 18(6):1294-304. PubMed ID: 22468935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.
    Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
    Drug Deliv Transl Res; 2018 Feb; 8(1):204-225. PubMed ID: 29204927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design.
    Shah U; Joshi G; Sawant K
    Mater Sci Eng C Mater Biol Appl; 2014 Feb; 35():153-63. PubMed ID: 24411363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
    Lee KR; Kim EJ; Seo SW; Choi HK
    Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement.
    Mori D; Makwana J; Parmar R; Patel K; Chavda J
    Pak J Pharm Sci; 2016 Nov; 29(6):1927-1936. PubMed ID: 28375107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.